Drug Profile
Immunoglobulin E vaccine - Pfizer
Alternative Names: Anti-IgE vaccine - Pfizer; Anti-immunoglobulin-E vaccine - Pfizer; IGE-1; IGE-2; PF-06444752; PF-06444753; PF-6444752; PF-6444753Latest Information Update: 24 Oct 2021
Price :
$50
*
At a glance
- Originator Pfizer
- Class Allergy immunotherapies; Vaccines; Virus-like particle vaccines
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Asthma; Perennial allergic rhinitis
Most Recent Events
- 22 Mar 2016 Safety and immunogenicity data from a phase I trial in Asthma was presented at the 2016 Annual Meeting of the American Academy of Allergy, Asthma and Immunology (AAAAI-2016)
- 28 Oct 2015 Discontinued - Phase-I for Asthma (IM)
- 28 Oct 2015 Discontinued - Phase-I for Perennial allergic rhinitis in Canada (IM)